About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02231411

Neonatal Resuscitation With Intact Cord

The purpose of this study is to examine whether providing ventilation during delayed umbilical cord clamping provides greater placental transfusion and improved hemodynamic transition at birth.

Lead sponsor: Sharp HealthCare•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Sharp HealthCare

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Subjects will receive 1 minute of delayed cord clamping in both arms. One arm will receive routine care, warm dry and stimulate during the 1 minutes transfusion. The second arm will receive routine care PLUS administration of CPAP and if need positive pressure ventilation. The outcome is to determine whether the addition of ventilation provides a larger placental transfusion and a smoother transition at birth.

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Gestational Age: Women admitted 23+0 to 31+6 weeks (Reason: Highest risk for IVH)

Exclusion Criteria

•Gestational Age: Parents decline consent (Reason: Can only perform intervention at time of delivery)
•Congenital anomalies of newborn (Reason: Exclude the effect of abnormal hematological function)
•Placental abruption (Reason: Exclude pregnancies at risk for hemorrhage at the time of delivery)
•Twin to twin transfusion (Reason: Exclude possible loss of blood from other twin during delayed cord clamping)
•Placenta Accreta
•Prolonged premature rupture of membranes (\> 2 weeks) prior to 23 weeks gestation

Related studies

Lumbar Drainage of Intraventricular Hemorrhage

NCT06510842 · Intraventricular Hemorrhage, Lumbar Drainage, and more

RAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH

NCT07205263 · Basal Ganglia Hemorrhage, Intraventricular Hemorrhage, and more

AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis

NCT05649904 · Intraventricular Hemorrhage, Subarachnoid Hemorrhage, and more

Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy

NCT05708105 · Intraventricular Hemorrhage of Newborn Grade 2, Intraventricular Hemorrhage of Newborn Grade 3, and more

RECRUITINGPhase 1

rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage

NCT06814964 · Intraventricular Hemorrhage

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 30, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment150

Start dateAug 2014

Last updatedMay 30, 2017

Condition

Intraventricular Hemorrhage

Locations shown

Sharp Mary Birch Hospital for Women and Newborns

San Diego, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 30, 2017Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions